These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18063603)

  • 1. Treatment of zygomycosis: current and new options.
    Rogers TR
    J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i35-40. PubMed ID: 18063603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZYGOMYCOSIS: current approaches to management of patients with haematological malignancies.
    Pagano L; Valentini CG; Caira M; Fianchi L
    Br J Haematol; 2009 Sep; 146(6):597-606. PubMed ID: 19466966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation of zygomycosis.
    Mantadakis E; Samonis G
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():15-20. PubMed ID: 19754751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
    Bourke P; Castro P; Rabagliati R; Beltran C; Verdejo H; Winter JL; Bourge RC
    Transpl Infect Dis; 2012 Oct; 14(5):E56-9. PubMed ID: 22852999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature.
    Page RL; Schwiesow J; Hilts A
    Pharmacotherapy; 2007 Feb; 27(2):290-8. PubMed ID: 17253919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current experience in treating invasive zygomycosis with posaconazole.
    Cornely OA; Vehreschild JJ; Rüping MJ
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():77-81. PubMed ID: 19754763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global epidemiology of cutaneous zygomycosis.
    Skiada A; Rigopoulos D; Larios G; Petrikkos G; Katsambas A
    Clin Dermatol; 2012; 30(6):628-32. PubMed ID: 23068150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis.
    Tragiannidis A; Groll AH
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():82-6. PubMed ID: 19754764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Zygomycetes and zygomycosis in the new era of antifungal therapies].
    Torres-Narbona M; Guinea J; Muñoz P; Bouza E
    Rev Esp Quimioter; 2007 Dec; 20(4):375-86. PubMed ID: 18563211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous zygomycosis.
    Bonifaz A; Vázquez-González D; Tirado-Sánchez A; Ponce-Olivera RM
    Clin Dermatol; 2012; 30(4):413-9. PubMed ID: 22682190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Invasive zygomycosis in patients treated for haematological malignancies].
    Verweij PE; van der Velden WJ; Donnelly JP; Blijlevens NM; Warris A
    Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2597-602. PubMed ID: 18161258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten years' experience in zygomycosis at a tertiary care centre in India.
    Chakrabarti A; Das A; Sharma A; Panda N; Das S; Gupta KL; Sakhuja V
    J Infect; 2001 May; 42(4):261-6. PubMed ID: 11545569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zygomycosis: the re-emerging fungal infection.
    Chayakulkeeree M; Ghannoum MA; Perfect JR
    Eur J Clin Microbiol Infect Dis; 2006 Apr; 25(4):215-29. PubMed ID: 16568297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Zygomycosis].
    Takakura S
    Nihon Rinsho; 2008 Dec; 66(12):2356-61. PubMed ID: 19069105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Invasive zygomycosis: notably in diabetes mellitus and iron overload].
    Kullberg BJ; van 't Wout JW
    Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2603-5. PubMed ID: 18161259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of zygomycosis cases by pooled analysis method reported from Turkey].
    Zeka AN; Taşbakan M; Pullukçu H; Sipahi OR; Yamazhan T; Arda B
    Mikrobiyol Bul; 2013 Oct; 47(4):708-16. PubMed ID: 24237440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.